Remove Manufacturing Remove Pharma Remove Physicians Remove Safety
article thumbnail

PhRMA lies to protect pharma profits

World of DTC Marketing

Such warnings “constitute the pharma response in literally every instance since 1906,” the first drug regulation agency was created, said Dr. Aaron Kesselheim. About 40 percent of drugs fail in preliminary Phase I studies, which assess a drug’s safety in humans and typically cost just $25 million.

Pharma 255
article thumbnail

Developing point-of-care CAR T manufacturing

European Pharmaceutical Review

2,3 Clinical implementation of CAR T-cell technology requires a reproducible T-cell manufacturing platform, which necessitates effective gene-transfer tools and T-cell culture conditions. Due to shipping and manufacturing requirements, the time from a patient being included in the CAR T programme to receiving therapy can be several weeks.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Future of Biosimilars Marketing

PM360

biosimilars market is evolving rapidly and pharma marketing programs need to evolve as well to better meet physician needs. As we found in our latest physician survey, physicians are actively seeking more information on key topics such as patient affordability, patient eligibility, clinical results, formulary coverage, and more.

article thumbnail

How to Boost Pharma Sales AI Training with AI Insights

Quantified

In response, forward-thinking corporate decision-makers nationwide are turning to cutting-edge pharma sales AI training to optimize the impact of every human interaction. How Artificial Intelligence Amplifies the Benefits of Pharma Rep Role-Play The role of the pharma sales rep is clearly evolving.

article thumbnail

Fixed-dose combination: Considerations for design, formulation, manufacturing and analysis

Pharmaceutical Technology

Understanding both the significant competitive advantages that FDC products can offer, and the difficulties and potential pitfalls associated with development and manufacturing of FDC drugs in oral solid dosage forms is a critical first step for companies exploring this approach. More FDC products flowing into pharma pipelines.

article thumbnail

Leading speciality pharmacies in pharma

Pharmaceutical Technology

Pharmaceutical Technology has listed the top speciality pharmacies in pharma based on its intel, insights, and decades of experience in the sector. Communication and follow-up with the physician. Patient monitoring for safety and efficacy. Payer and/or manufacturer reporting. Patient monitoring for safety and efficacy.

article thumbnail

US legislative update: takeaways for European pharma

European Pharmaceutical Review

For example, the US recently passed the Inflation Reduction Act, 1 which requires the Secretary of Health and Human Services (HHS) to negotiate prices for certain physician-administered and retail prescription drugs covered under Medicare Parts B and D. 3) policing anticompetitive settlements between competing drug manufacturers.